Chauhan Bhushan, Arya Shantanu, Chauhan Komal
Department of ENT, M. M. Institute of Medical Sciences and Research, MMDU, Mullana, Ambala, Haryana, India.
National Institute of Food Technology Entrepreneurship and Management, Kundli, Sonipat, Haryana, India.
J Audiol Otol. 2023 Jan;27(1):37-44. doi: 10.7874/jao.2022.00395. Epub 2023 Jan 10.
Tinnitus, or ear ringing, involves impulsive and spontaneous activity in the auditory neurons. Its prevalence is high in the elderly, but 10%-15% of adults suffer from tinnitus, affecting their quality of life. Therefore, this study aimed to evaluate the efficacy of Ginkgo biloba administered singly and in combination with antioxidants in tinnitus patients. Subjects and.
Patients were randomly allocated to Placebo (T0, n=22), Treatment 1 (T1, n=24), and Treatment 2 (T2, n=23) groups. The patients were educated on the study's methodology and were instructed to visit at 0, 4, 8, 12, and 14 weeks. The placebo group received starch capsule supplements. Conversely, the treatment groups received Ginkgo biloba (60 mg twice a day) singly and in combination with antioxidants. We enrolled 69 patients aged 40-70 years (41 men, 28 women). The Tinnitus Handicap Index (THI), Visual Analogue Score (VAS), and Short Form 36 (SF-36) Health Scores were determined pre- and post-treatment at each visit.
Supplementation of Ginkgo biloba, along with antioxidants, provided marked improvement (p<0.05) in post-treatment THI and VAS scores in the T2 group compared to those in the T1 and T0 groups. The greatest (p<0.05) percent difference was observed in the pre- and post-treatment THI (-36%) and VAS scores (-22.6%) of T2 patients. Likewise, the SF-36 scores improved significantly (p<0.05) in the T2 group in varied parameters.
Ginkgo biloba, along with antioxidants, can be a promising therapy for tinnitus patients, providing marked improvement in THI, VAS, and SF-36 scores.
耳鸣,即耳内鸣响,涉及听觉神经元的冲动性和自发性活动。耳鸣在老年人中患病率很高,但10% - 15%的成年人患有耳鸣,影响他们的生活质量。因此,本研究旨在评估单独使用银杏叶以及与抗氧化剂联合使用对耳鸣患者的疗效。受试者与……
将患者随机分为安慰剂组(T0,n = 22)、治疗1组(T1,n = 24)和治疗2组(T2,n = 23)。向患者介绍了研究方法,并指示他们在第0、4、8、12和14周前来就诊。安慰剂组接受淀粉胶囊补充剂。相反,治疗组分别单独接受银杏叶(每日两次,每次60毫克)以及与抗氧化剂联合使用。我们招募了69名年龄在40 - 70岁之间的患者(41名男性,28名女性)。在每次就诊时,于治疗前后测定耳鸣障碍指数(THI)、视觉模拟评分(VAS)和简短健康调查问卷36项(SF - 36)健康评分。
与T1组和T0组相比,T2组在治疗后THI和VAS评分方面,银杏叶与抗氧化剂联合使用有显著改善(p < 0.05)。T2组患者治疗前后THI(-36%)和VAS评分(-22.6%)的差异百分比最大(p < 0.05)。同样,T2组在SF - 36评分的各项参数上也有显著改善(p < 0.05)。
银杏叶与抗氧化剂联合使用,对于耳鸣患者可能是一种有前景的治疗方法,可显著改善THI、VAS和SF - 36评分。